Jun Tan

Prof. Jun Tan


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 May 2020 in American Journal of Reproductive Immunology
Verified
Journal Article
Closed access
PDF file
ZYZiwei Yang
Ziwei Yang
ZTZijuan Tang
Zijuan Tang
XCXiuping Cao
Xiuping Cao
QXQi Xie
Qi Xie
CHChuan Hu
Chuan Hu
YZYue-Hui Zheng
Yue-Hui Zheng

1 March 2023 in Frontiers in Immunology
Verified
Journal Article
Open access
QXQi Xie
Qi Xie
WHWenli Hong
Wenli Hong
YLYuan Li
Yuan Li
SLShuyi Ling
Shuyi Ling
ZZZiqiong Zhou
Ziqiong Zhou
YZYue-Hui Zheng
Yue-Hui Zheng
Introduction: Polycystic Ovary Syndrome (PCOS) is the most common reproductive endocrine disorder among women of reproductive age, which is one of the main causes of anovulatory infertility. Even though the rapidly developed assisted reproductive technology (ART) could effectively solve fertility problems, some PCOS patients still have not obtained satisfactory clinical outcomes. The poor quality of oocytes caused by the abnormal follicular development of PCOS may directly contribute to the failure of ART treatment. Ovarian granulosa cells (GCs) are the most closely related cells to oocytes, and changes in their functional status have a direct impact on oocyte formation. Previous studies have shown that changes in the ovarian microenvironment, like oxidative stress and inflammation, may cause PCOS-related aberrant follicular development by impairing the physiological state of the GCs. Therefore, optimizing the ovarian microenvironment is a feasible method for enhancing the development potential of PCOS oocytes.Methods: In this study, we first detected the expression of inflammatory-related factors (TGF-β1, IL-10, TNFα, IL-6) and oxidative stress-related factors (HIF-1α and VEGFA), as well as the proliferation ability and apoptosis level of GCs, which were collected from control patients (non-PCOS) and PCOS patients, respectively. Subsequently, human ovarian granulosa cell line (KGN) cells were used to verify the anti-inflammatory and anti-oxidative stress effects of chitosan oligosaccharide (COS) on GCs, as well as to investigate the optimal culture time and concentration of COS. The optimal culture conditions were then used to culture GCs from PCOS patients and control patients.Results: The results showed that GCs from PCOS patients exhibited obvious inflammation and oxidative stress and significantly reduced proliferation and increased apoptosis. Furthermore, COS can increase the expression of anti-inflammatory factors (TGF-β1 and IL-10) and decrease the expression of pro-inflammatory factors (TNFα and IL-6), as well as promote the proliferation of GCs. Moreover, we found that COS can reduce the level of reactive oxygen species in GCs under oxidative stress by inhibiting the expression of HIF-1α and VEGFA and by suppressing the apoptosis of GCs induced by oxidative stress.Conclusion: We find that inflammation and oxidative stress exist in the GCs of PCOS patients, and COS can reduce these factors, thereby improving the function of GCs.

1 January 2022 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
ZYZiwei Yang
Ziwei Yang
WHWenli Hong
Wenli Hong
KZK. Zheng
K. Zheng
JFJingyuan Feng
Jingyuan Feng
CHChuan Hu
Chuan Hu
YZYue-Hui Zheng
Yue-Hui Zheng
Oocyte maturation disorder and decreased quality are the main causes of infertility in women, and granulosa cells (GCs) provide the only microenvironment for oocyte maturation through autocrine and paracrine signaling by steroid hormones and growth factors. However, chronic inflammation and oxidative stress caused by ovarian hypoxia are the largest contributors to ovarian aging and GC dysfunction. Therefore, the amelioration of chronic inflammation and oxidative stress is expected to be a pivotal method to improve GC function and oocyte quality. In this study, we detected the protective effect of chitosan oligosaccharides (COS), on hydrogen peroxide‐ (H2O2‐) stimulated oxidative damage in a human ovarian granulosa cell line (KGN). COS significantly increased cell viability, mitochondrial function, and the cellular glutathione (GSH) content and reduced apoptosis, reactive oxygen species (ROS) content, and the levels of 8‐hydroxy‐2 ′‐deoxyguanosine (8‐OHdG), 4‐hydroxynonenal (4‐HNE), hypoxia‐inducible factor‐1α (HIF‐1α), and vascular endothelial‐derived growth factor (VEGF) in H2O2‐stimulated KGN cells. COS treatment significantly increased levels of the TGF‐β1 and IL‐10 proteins and decreased levels of the IL‐6 protein. Compared with H2O2‐stimulated KGN cells, COS significantly increased the levels of E2 and P4 and decreased SA‐β‐gal protein expression. Furthermore, COS caused significant inactivation of the HIF‐1α‐VEGF pathway in H2O2‐stimulated KGN cells. Moreover, inhibition of this pathway enhanced the inhibitory effects of COS on H2O2‐stimulated oxidative injury and apoptosis in GCs. Thus, COS protected GCs from H2O2‐stimulated oxidative damage and apoptosis by inactivating the HIF‐1α‐VEGF signaling pathway. In the future, COS might represent a therapeutic approach for ameliorating disrupted follicle development.

19 May 2021 in Gynecological Endocrinology
Verified
Journal Article
Closed access
SPShao-Lan Peng
Shao-Lan Peng
QWQiong-Fang Wu
Qiong-Fang Wu
QXQi Xie
Qi Xie
JTJun Tan
Jun Tan
KSKuan-Yong Shu
Kuan-Yong Shu
PCOS often showed abnormal follicular development. Previous studies have found that the increased apoptosis of granulosa cells (GCs) is one of the key factors leading to follicular dysplasia. It ha... 目的:多囊卵巢综合征常表现为卵泡发育异常。已有研究发现, 卵巢颗粒细胞(granulosa cells, GCs)凋亡增加是导致卵泡发育不良的关键因素之一。研究发现, PATL2功能的降低或缺失可显著抑制人卵母细胞的发育和成熟。我们发现PATL2在人GCs中也有表达, 提示PATL2可能参与了GCs相关生物学事件的调控。本研究旨在探讨PATL2对GCs凋亡的调节作用, 以及PATL2在PCO...

4 February 2022 in Reproductive Biology and Endocrinology
Verified
Journal Article
Open access
PDF file
DXDing-Fei Xu
Ding-Fei Xu
PLPei-Pei Liu
Pei-Pei Liu
LFLu Fan
Lu Fan
QXQi Xie
Qi Xie
ZZZhi-Qin Zhang
Zhi-Qin Zhang
JTJun Tan
Jun Tan
Background: Several surveys have reported that patients treated with gonadotropin-releasing hormone antagonist (GnRH-ant) protocol showed a significantly lower rate of implantation and clinical pregnancy compared to GnRH agonist (GnRH-a) protocol during in vitro fertilization-fresh embryo transfer. Subsequent studies imputed this poor outcome to the negative effects of GnRH-ant on endometrial receptive. However, the mechanisms were not fully understood. Methods: The clinical data of 2815 patients undergoing fresh embryo transfer in our center were analyzed. Human endometrial stromal cells (ESCs) from healthy women undergoing elective pregnancy termination of a normal pregnancy at 8–10 weeks gestation were treated with GnRH-analogs or imatinib (c-kit receptor inhibitor). CCK8 and Flow cytometry were used to investigated the growth ability of ESCs. Immunofluorescence staining and western blot was used to detected the target proteins. Results: The clinical data showed that the endometrial thickness on HCG Day were significantly lower in GnRH-ant group. Although no difference of embryo quality in these two groups, GnRH-ant group showed remarkably decreased rate of HCG positive, embryo implantation and pregnancy. Moreover, GnRH-ant significantly reduced the proliferation and induced the apoptosis of ESCs. Furthermore, the expression and activation of c-kit receptor, which played pivotal roles during embryo implantation, were observably decreased by GnRH-ant. Inhibiting the activation of c-kit by imatinib remarkably suppressed the proliferation and promoted the apoptosis of ESCs. Additionally, the phosphorylation of AKT and expression of Cyclin D1, which were closely related with cellular growth, were distinctly lessened after treating with imatinib. Conclusions: In summary, our study showed that GnRH-ant weakened the activization of c-kit receptor by decreasing its expression, causing the impaired growth ability of ESCs. Our findings provided a new insight into the effects of GnRH-ant on endometrium.

8 November 2022 in Journal of Medical Virology
Verified
Journal Article
Closed access
JHJialyu Huang
Jialyu Huang
ZFZheng Fang
Zheng Fang
LHLingling Huang
Lingling Huang
LFLu Fan
Lu Fan
YLYiqi Liu
Yiqi Liu
QWQiongfang Wu
Qiongfang Wu